sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease

被引:46
作者
Yan, Xiaohua [1 ,2 ]
Xu, Liyun [1 ]
Qi, Jianni [1 ]
Liang, Xiaohong [1 ]
Ma, Chunhong [1 ]
Guo, Chun [1 ]
Zhang, Lining [1 ]
Sun, Wensheng [1 ]
Zhang, Jiyun [2 ]
Wei, Xiaoyi [2 ]
Gao, Lifen [1 ]
机构
[1] Shandong Univ, Sch Med, Dept Immunol, Jinan 250012, Peoples R China
[2] Shandong Med Coll, Linyi 276002, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL); Single-nucleotide polymorphism (SNP); Fatty liver disease (FLD); NONALCOHOLIC STEATOHEPATITIS; MULTIPLE-SCLEROSIS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; INDUCED APOPTOSIS; SOLUBLE TRAIL; RISK-FACTORS; TNF-ALPHA; HEPATOCYTES; EXPRESSION;
D O I
10.1007/s00251-009-0389-4
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学];
摘要
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily, and has been identified as a novel mediator of fatty liver disease (FLD). The aim of our study was to further investigate the relationship between TRAIL and FLD. We found that soluble TRAIL (sTRAIL) concentrations in non-alcoholic FLD (NAFLD) patients were significantly higher than those of controls, and that sTRAIL levels positively correlated with triglyceride concentrations in NAFLD patients. Our results also indicated that the AA/TT genotypes of TRAIL at 1525/1595 engendered a lower risk of FLD attack and a less severe form of steatosis for NAFLD patients in Chinese population. This study provides a means to test for susceptibility to FLD and may assist in the diagnosis of FLD. In addition, we found that 1525G/A and 1595C/T sites were in complete linkage disequilibrium in Chinese population. This might indicate a haplotype with high genetic frequency of TRAIL.
引用
收藏
页码:551 / 556
页数:6
相关论文
共 33 条
[1]
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease [J].
Adams, LA ;
Lindor, KD ;
Angulo, P .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (07) :1316-1320
[2]
Hepatitis C - Following the TRAIL from hepatitis C virus and alcohol to fatty liver [J].
Afford, SC ;
Adams, DH .
GUT, 2005, 54 (11) :1518-1520
[3]
Inhibition of matrix metalloproteinases increases PPAR-α and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model [J].
Alwayn, Ian P. J. ;
Andersson, Charlotte ;
Lee, Sang ;
Arsenault, Danielle A. ;
Bistrian, Bruce R. ;
Gura, Kathleen M. ;
Nose, Vania ;
Zauscher, Blanca ;
Moses, Marsha ;
Puder, Mark .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 291 (06) :G1011-G1019
[4]
Apo2L/TRAIL and immune regulation [J].
Anel, Alberto ;
Bosque, Alberto ;
Naval, Javier ;
Pineiro, Andres ;
Larrad, Luis ;
Angeles Alava, Maria ;
Jose Martinez-Lorenzo, Maria .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 :2074-2084
[5]
Bahcecioglu IH, 2005, HEPATO-GASTROENTEROL, V52, P1549
[6]
Heritability and genetic loci of fatty liver in familial combined hyperlipidemia [J].
Brouwers, Martijn C. G. J. ;
Cantor, Rita M. ;
Kono, Naoko ;
Yoon, Jeong Lim ;
van der Kallen, Carla J. H. ;
Bilderbeek-Beckers, Monique A. L. ;
van Greevenbroek, Marleen M. J. ;
Lusis, Aldons J. ;
de Bruin, Tjerk W. A. .
JOURNAL OF LIPID RESEARCH, 2006, 47 (12) :2799-2807
[7]
Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion [J].
Chavin, KD ;
Yang, SQ ;
Lin, HZ ;
Chatham, J ;
Chacko, VP ;
Hoek, JB ;
Walajtys-Rode, E ;
Rashid, A ;
Chen, CH ;
Huang, CC ;
Wu, TC ;
Lane, MD ;
Diehl, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (09) :5692-5700
[8]
Choi JW, 2004, ANN CLIN LAB SCI, V34, P400
[9]
Three polymorphisms in the 3′ UTR of the TRAIL (TNF-related apoptosis-inducing ligand) gene [J].
Gray, HL ;
Sorensen, EL ;
Hunt, JS ;
Ober, C .
GENES AND IMMUNITY, 2001, 2 (08) :469-470
[10]
Detection of soluble TRAIL in HBV infected patients and its clinical implications [J].
Han, LH ;
Sun, WS ;
Ma, CH ;
Zhang, LN ;
Liu, SX ;
Zhang, Q ;
Gao, LF ;
Chen, YH .
WORLD JOURNAL OF GASTROENTEROLOGY, 2002, 8 (06) :1077-1080